Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1006 AL 1020

Associations between antipsychotics exposure and dementia risk: A prospective cohort study of 415,100 participants

Ma LY, Ou YN, Gao PY, Fu Y, Zhang DD, Yang L, Feng JF, Cheng W, Tan L, Yu JT.

J Affect Disord. 2024 Mar 15;349:201-209. doi: 10.1016/j.jad.2024.01.029. Epub 2024 Jan 8.

The Therapeutic Effects of Noninvasive Brain Stimulation Combined with Cognitive Training in Elders with Alzheimer's Disease or Amnesic Mild Cognitive Impairment

Wang JY, Qin JY, Ye JY, Li WT, Tong MQ, Ouyang H, Yan FX.

J Prev Alzheimers Dis. 2024;11(1):222-229. doi: 10.14283/jpad.2024.1.

Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method

Nous A, Seynaeve L, Feys O, Wens V, De Tiège X, Van Mierlo P, Baroumand AG, Nieboer K, Allemeersch GJ, Mangelschots S, Michiels V, van der Zee J, Van Broeckhoven C, Ribbens A, Houbrechts R, De Witte S, Wittens MMJ, Bjerke M, Vanlersberghe C, Ceyssens S, Nagels G, Smolders I, Engelborghs S.

Alzheimers Res Ther. 2024 Jan 23;16(1):19. doi: 10.1186/s13195-023-01373-9.

Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review

Corasaniti MT, Bagetta G, Nicotera P, Maione S, Tonin P, Guida F, Scuteri D.

Int J Mol Sci. 2024 Jan 19;25(2):1264. doi: 10.3390/ijms25021264.

A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol

Barbera M, Lehtisalo J, Perera D, Aspö M, Cross M, De Jager Loots CA, Falaschetti E, Friel N, Luchsinger JA, Gavelin HM, Peltonen M, Price G, Neely AS, Thunborg C, Tuomilehto J, Mangialasche F, Middleton L, Ngandu T, Solomon A, Kivipelto M; MET-FINGER study team.

Alzheimers Res Ther. 2024 Jan 31;16(1):23. doi: 10.1186/s13195-023-01355-x.

Case report: a unique presentation of memantine overdose causing echolalia and hypertension

Durrani S, Ahmed S.

BMC Geriatr. 2024 Feb 1;24(1):123. doi: 10.1186/s12877-024-04658-2.

Intriguing review and topics in this month of Hypertension Research

Hoshide S, Mogi M, Kario K.

Hypertens Res. 2024 Feb;47(2):253-254. doi: 10.1038/s41440-023-01532-3. Epub 2024 Feb 5.

Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer's disease

Zuliani G, Zuin M, Romagnoli T, Polastri M, Cervellati C, Brombo G.

Aging Clin Exp Res. 2024 Feb 7;36(1):23. doi: 10.1007/s40520-023-02675-6.

Repurposing Erectile Dysfunction Medication for Alzheimer Disease Prevention

Yasar S, Nidadavolu L.

Neurology. 2024 Feb 27;102(4):e209180. doi: 10.1212/WNL.0000000000209180. Epub 2024 Feb 7.

Unveiling the role of astrocytes in postoperative cognitive dysfunction

He L, Duan X, Li S, Zhang R, Dai X, Lu M.

Ageing Res Rev. 2024 Mar;95:102223. doi: 10.1016/j.arr.2024.102223. Epub 2024 Feb 5.

Anti-Amyloid Therapies for Alzheimer's Disease: An Alzheimer Europe Position Paper and Call to Action

Bradshaw AC, Georges J.

J Prev Alzheimers Dis. 2024;11(2):265-273. doi: 10.14283/jpad.2024.37.

Nanolithium, a New Treatment Approach to Alzheimer's Disease: A Review of Existing Evidence and Clinical Perspectives

Guilliot S, Wilson EN, Touchon J, Soto ME.

J Prev Alzheimers Dis. 2024;11(2):428-434. doi: 10.14283/jpad.2024.26.

Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders

Pei MQ, Xu LM, Yang YS, Chen WC, Chen XL, Fang YM, Lin S, He HF.

Brain Res. 2024 May 1;1830:148821. doi: 10.1016/j.brainres.2024.148821. Epub 2024 Feb 23.

Advances in nanoprobes for molecular MRI of Alzheimer's disease

Parekh P, Badachhape AA, Tanifum EA, Annapragada AV, Ghaghada KB.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr;16(2):e1946. doi: 10.1002/wnan.1946.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias